Vaxart Inc (VXRT)
0.7625
+0.01
(+0.91%)
USD |
NASDAQ |
Apr 22, 16:00
0.8357
+0.07
(+9.60%)
After-Hours: 07:55
Vaxart Profit Margin (Quarterly): -262.3% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -262.3% |
| September 30, 2023 | -3.90K% |
| June 30, 2023 | -1.66K% |
| March 31, 2023 | -3.72K% |
| December 31, 2022 | -108.7K% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -29.53K% |
| December 31, 2021 | -28.06K% |
| September 30, 2021 | -8.79K% |
| June 30, 2021 | -14.39K% |
| March 31, 2021 | -3.16K% |
| December 31, 2020 | -3.89K% |
| September 30, 2020 | -3.05K% |
| June 30, 2020 | -1.72K% |
| March 31, 2020 | -44.69% |
| December 31, 2019 | -163.7% |
| September 30, 2019 | -1.16K% |
| June 30, 2019 | -6.63K% |
| March 31, 2019 | -24.76% |
| December 31, 2018 | -277.4% |
| September 30, 2018 | -2.33K% |
| June 30, 2018 | -1.46K% |
| March 31, 2018 | |
| December 31, 2017 | -125.9% |
| Date | Value |
|---|---|
| September 30, 2017 | -5.30K% |
| June 30, 2017 | -5.90K% |
| March 31, 2017 | -89.80% |
| December 31, 2016 | -239.5% |
| September 30, 2016 | -10.00K% |
| June 30, 2016 | -1.40K% |
| March 31, 2016 | -98.11% |
| December 31, 2015 | -382.4% |
| September 30, 2015 | -388.2% |
| June 30, 2015 | -485.4% |
| March 31, 2015 | 20.34% |
| December 31, 2014 | 46.76% |
| September 30, 2014 | -985.7% |
| June 30, 2014 | -121.4% |
| March 31, 2014 | 10.85% |
| December 31, 2013 | -0.54% |
| September 30, 2013 | -31.71% |
| June 30, 2013 | -72.42% |
| March 31, 2013 | 1.72% |
| December 31, 2012 | 46.50% |
| September 30, 2012 | -647.2% |
| June 30, 2012 | -433.1% |
| March 31, 2012 | -68.99% |
| December 31, 2011 | -238.3% |
| September 30, 2011 | 7.18% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-108.7K%
Minimum
Dec 2022
-44.69%
Maximum
Mar 2020
-12.87K%
Average
-3.72K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Novavax Inc | -70.40% |
| aTyr Pharma Inc | -- |
| Allogene Therapeutics Inc | -- |
| AIM ImmunoTech Inc | -19.35K% |
| Protalix BioTherapeutics Inc | -57.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -99.42% |
| Return on Assets | -68.29% |
| Return on Invested Capital | -99.42% |
| Operating Margin (Quarterly) | -255.1% |
| Return on Net Operating Assets | -155.9% |